These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25656408)

  • 21. [Treatment of onychomycosis].
    Feuilhade de Chauvin M
    J Mycol Med; 2014 Dec; 24(4):296-302. PubMed ID: 25458366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of onychomycosis in patients attending a dermatology center in Tehran, Iran.
    Soltani M; Khosravi AR; Shokri H; Sharifzadeh A; Balal A
    J Mycol Med; 2015 Jun; 25(2):e81-7. PubMed ID: 25952331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine.
    Gianni C; Romano C
    Dermatology; 2004; 209(2):104-10. PubMed ID: 15316163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast.
    Gallo L; Cinelli E; Fabbrocini G; Vastarella M
    Mycoses; 2019 Aug; 62(8):659-664. PubMed ID: 31062415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of onychomycosis: prevailing fungi and pattern of infection.
    Veer P; Patwardhan NS; Damle AS
    Indian J Med Microbiol; 2007 Jan; 25(1):53-6. PubMed ID: 17377354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
    Kaçar N; Ergin S; Ergin C; Erdogan BS; Kaleli I
    Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of onychomycosis in Isfahan, Iran.
    Chadeganipour M; Nilipour S; Ahmadi G
    Mycoses; 2010 Mar; 53(2):153-7. PubMed ID: 19298358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onychomycosis in Northern Greece during 1994-1998.
    Koussidou T; Devliotou-Panagiotidou D; Karakatsanis G; Minas A; Mourellou O; Samara K
    Mycoses; 2002 Feb; 45(1-2):29-37. PubMed ID: 11856434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do fungi play a role in psoriatic nails?
    Szepietowski JC; Salomon J
    Mycoses; 2007 Nov; 50(6):437-42. PubMed ID: 17944702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onychomycosis: Clinico-mycologic study of 130 patients from Himachal Pradesh, India.
    Gupta M; Sharma NL; Kanga AK; Mahajan VK; Tegta GR
    Indian J Dermatol Venereol Leprol; 2007; 73(6):389-92. PubMed ID: 18032856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection.
    Vélez A; Linares MJ; Fenández-Roldán JC; Casal M
    Mycopathologia; 1997; 137(1):1-8. PubMed ID: 9299751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs.
    Falahati M; Ghojoghi A; Abastabar M; Ghasemi Z; Farahyar S; Roudbary M; Hedayati MT; Armaki MT; Hoseinnejad A
    Mycopathologia; 2016 Apr; 181(3-4):273-7. PubMed ID: 26474550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts.
    Fatahinia M; Jafarpour S; Rafiei A; Taghipour S; Makimura K; Rezaei-Matehkolaei A
    Curr Med Mycol; 2017 Dec; 3(4):26-31. PubMed ID: 29707676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic and clinicomycologic profile of onychomycosis from north India.
    Sarma S; Capoor MR; Deb M; Ramesh V; Aggarwal P
    Int J Dermatol; 2008 Jun; 47(6):584-7. PubMed ID: 18477149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-dermatophyte mold onychomycosis in Sri Lanka.
    Ranawaka RR; de Silva N; Ragunathan RW
    Dermatol Online J; 2012 Jan; 18(1):7. PubMed ID: 22301044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 5-year single-center study about onychomycosis with a focus on Aspergillus spp. in Albania.
    Fida M; Prendushi XF; Gjylameti N; Dedej S; Zenelaj V; Toçi E; Vasili E
    Int J Dermatol; 2023 Nov; 62(11):1365-1370. PubMed ID: 37735716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onychomycosis in Cali, Colombia.
    Alvarez MI; González LA; Castro LA
    Mycopathologia; 2004 Aug; 158(2):181-6. PubMed ID: 15518346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp. nov., with implications to antifungal susceptibility testing.
    Tsang CC; Hui TW; Lee KC; Chen JH; Ngan AH; Tam EW; Chan JF; Wu AL; Cheung M; Tse BP; Wu AK; Lai CK; Tsang DN; Que TL; Lam CW; Yuen KY; Lau SK; Woo PC
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):125-34. PubMed ID: 26658315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
    Xu X; Naseri A; Houbraken J; Akbari F; Wang X; Zhao R; Zhang H; Najafzadeh MJ; Deng S
    Sci Rep; 2021 Mar; 11(1):6808. PubMed ID: 33762586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onychomycosis in Taiwan.
    Wang SH; Chi CC
    Int J Clin Pract; 2005 Aug; 59(8):906-11. PubMed ID: 16033611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.